These updates includes material published by third parties and compiled by PAHO. PAHO has taken reasonable precautions to verify the information contained in the document. However, this material is being distributed without warranty of any kind. The reader is responsible for the interpretation and use of this information and in no event shall PAHO be held liable for any damages arising from its use.
  • Updates
  • Clarifications/conclusions of events presented in previous communications
  • Other related updates


Read more

FDA and CDC pause on the use of Janssen COVID-19 vaccine (updated information)

Following a thorough review of the safety of the Johnson & Johnson (Janssen) COVID-19 vaccine in the United States, including two meetings of the CDC's Advisory Committee on Immunization Practices (ACIP), FDA and the CDC have determined that the recommended pause in vaccine use should be lifted, and use of the vaccine resumed.

Read more

Collection of information on recently reported rare and severe events - April 2021

Use of the Janssen vaccine in the United States is temporarily suspended

Read more

Use of Janssen vaccine in the United States is temporarily suspended

As of 12 April 2021, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine had been administered in the United States

Read more